中國中冶(01618.HK):不參與通用五礦進一步增資,持股將降至6.28%
格隆匯 8 月 31日丨中國中冶(01618.HK)公佈,有關中冶系投資方獲得通用五礦20.67%的股權事項,yu 2020年8月31日,通用五礦的全體現有股東(包括中冶系投資方、五礦系投資方、環球醫投及中信資本)與兩家中國五礦的附屬公司(“”新投資方“”,與五礦系投資方合稱為“”新五礦系投資方“”)訂立重組協議,約定以現金及╱或資產注入的方式對通用五礦作進一步增資。於此次增資完成後,各方對通用五礦的出資總額將從人民幣84,700.08萬元增加至人民幣278,696.85萬元。
通用五礦主要從事零售藥品及醫院管理等業務,而此公司不擬增加在醫療行業等非公司主業的投資,因此中冶系投資方決定不參與此次增資,因而其於通用五礦的總持股比例將從20.67%下降至6.28%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.